Trial Profile
A Prospective, Observational Drug Utilization Study of Stribild in Adults with HIV-1 Infection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 14 Jun 2016 Planned End Date changed from 30 Jun 2016 to 30 Sep 2016.
- 13 Jun 2016 Planned End Date changed from 30 Nov 2015 to 30 Jun 2016.
- 18 Feb 2016 New trial record